Drugs / L03RD2
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07533539 | May 2026 overdue | type 2 diabetes mellitus | Celltrion | Active not recruiting | No outcome recorded |
| Phase 1 | NCT07158346 | Aug → Oct 2025 | type 2 diabetes mellitus | Celltrion | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L03RD2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07158346 ↗ |